Sentences with phrase «reduces currency risk»

One is that it reduces currency risk: if your expenses are in Canadian dollars, it makes sense to hold most of your assets in the same currency.
The reason is that the exposure for a Canadian investor is not to one currency but to a basket of currencies, which reduces currency risk substantially.
Our goal is to help our investors benefit from exposure to non-U.S. markets, while reducing currency risk.
While hedging is usually designed to reduce currency risk, CGL actually adds a layer of risk that wouldn't otherwise exist.
Finally issuance of bonds in local currencies can significantly reduce currency risk and improve the ability of the borrower to fulfill the bond requirement.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
But without a consensus from the economic community, it would be unwise to risk stamping out the economic recovery by sparking a trade war with China over currency disputes or drastically reducing the budget deficit.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
If you hedge half of your foreign holdings back into Canadian dollars, you can reduce your risk without making a specific bet on which way a currency will go.
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
The floating currency is helping to reduce the disinflationary risks that have come with the cut in our national income.
On other note, you can actually reduce your risks with cryptocurrency pairs as well, and get exposure only to the relative performance of two coins, and remove the generally huge volatility of coins versus fiat currencies, like Ethereum's swings against the Dollar on the chart above
We regard digital currency payments as «accepted» when one block confirmation has been registered, however, due to varying security between blockchains, we reserve the right to require additional block confirmations to reduce risk of fraudulent double spending attempts or errors related to forks.
The iShares Currency Hedged ETF's use of derivatives may reduce the funds» returns and / or increase volatility and subject the funds to counterparty risk, which is the risk that the other party in the transaction will not fulfill its contractual obligation.
Lars Kroijer proposes on this site and elsewhere holding an amount of bonds and gilts in one's domestic currency that is dependent on appetite for risk as bonds and gilts reduce the risk.
Businesses all over the world try to reduce risk that is connected with changes in currency values, stock prices, and interest rates.
«Internationally, it is considered that the extension of AML / CTF regulation to include convertible digital currency exchanges would encourage innovation and investment by ensuring service providers have greater certainty and security in their dealings with digital currency businesses, while reducing the money laundering and terrorism financing risks associated with this emerging technology.»
Our analysis shows that gold can be a cost effective EM - currency hedge, helping investors reduce portfolio losses during periods of heightened risk.
The currency remains inside the rising trend, but the risks of a correction are rising, and in the case of a break - out, traders should rather reduce their positions than open new ones.
This will allow you to make and receive payments in the same currency, reducing the risks of paying poor foreign exchange rates.
However, inherent risks such as contingent liability (where your liability may be greater than the initial purchase price of the investment), margining requirements (where you are required to make a series of payments against the purchase price, depending on whether the underlying investment or index is moving in your favour) and international exchanges (which can mean a reduced level of investor protection, as well as currency fluctuation if the investment is not traded in sterling) meant these were out of reach.
The iShares Currency Hedged Funds» use of derivatives may reduce the Funds» returns and / or increase volatility and subject the Funds to counterparty risk, which is the risk that the other party in the transaction will not fulfill its contractual obligation.
Schroder Multi-Asset Total Return Fund invests in a broad range of asset types, which can help to generate positive returns or reduce risk at different times.These include assets that are familiar to most, such as equities and bonds, along with assets in more specialist investment areas such as currencies and commodities.
Unless foreign currency positions constitute more than roughly one - quarter of portfolio assets, currency exposure serves to reduce the overall portfolio risk.
Investing in currencies can reduce the overall risk profile of your portfolio, as currencies have different and less volatile returns than stocks and bonds.
There are ways individual investors can hedge currency risk to reduce exposure to swings in foreign exchange rates, such as through a currency - hedged exchange traded fund.
Let me state that again: the currency hedge is NOT active management — it is pure risk management (you are reducing the beta of the portfolio for a Canadian investor).
We find that Canadian investors benefit from retaining currency risk in international equities, as foreign currency acts a natural diversifier that can reduce overall volatility
According to Claymore's website, the ETF adds currency hedging «to reduce the direct exposure to non-Canadian dollar currency risk for unitholders of such fund.»
Reduce the international allocation as retirement nears to cut back on currency risk somewhat.
These risks can include political or economical instability, changing currency rates, foreign taxes, reduced liquidity (difficulty selling securities held by a fund) and different regulatory or financial accounting standards.
These funds attempt to reduce systematic risk created by factors such as exposure to particular sectors, market - cap ranges, investment styles, currencies, or countries.
These risks can include political or economic instability, changing currency rates, foreign taxes, reduced liquidity (difficulty selling securities held by a fund) and different regulatory or financial accounting standards.
You also need to diversify your holdings within those asset classes and hold, in the case of a stock portfolio, a variety of stocks — from risky to less risky, in different currencies, in different industries — to reduce your risk exposure.
Learn how currency hedging can help reduce exchange rate risk for a portfolio of foreign stocks.
If these risks are not properly managed, the value of your investment may be reduced by adverse changes in foreign currency exchange rates and interest rates.
Be aware that when you invest in international markets you have the added risk that changes in currency exchange rates can increase or reduce your investment returns.
Some funds may be «currency hedged» to reduce this risk.
A strategy that offers the most useful information on when to enter or exit a trade is crucial for just about anyone in the currency market, thereby reducing the risks associated with entering the market wrongly.
Ariel uses these techniques in an attempt to decrease the strategy's exposure to changing security prices or foreign currency risk, or to reduce unintended tracking error versus its respective benchmarks, or to address other factors that affect security values.
The portfolio volatility could be further reduced by currency hedging, which historically has resulted in a better risk - adjusted return profile.
Although sovereign debt will always involve default risk, lending money to a national government in the country's own currency is referred to as a risk - free investment because with limits, the debt can be repaid by the borrowing government by raising their taxes, reducing spending, or simply printing more money.
In particular, LexisNexis ® Risk Solutions has high - lighted five key revisions to the current legislation that banks and other financial institutions must be aware of to remain compliant in their anti-money launder - ing provisions: • Pre-paid cash cards: to reduce financial crimes linked to anonymous pre - paid instruments, vendors will be required to conduct more stringent customer verification and the thresh - old will be reduced from $ 250 to $ 150 • Digital currencies: thorough customer due diligence controls will be required by all virtual cur - ing farmers, are vulnerable to unfair trading practices employed by partners in the chain.
To reduce risk, the city instantly changes bitcoin into Swiss currency.
The Bank of England and others are already exploring blockchain - enabled fiat currencies to reduce friction, cost, and risk, increase transparency and accountability, and improve oversight of the financial system.
The company's forthcoming products, which entered limited availability release today, promise to allow consumers and businesses to use digital currency easily, reducing much of the friction and risk that is currently associated with Bitcoin.
Officials are also looking at ways to reduce risks associated with cryptocurrency trading in the country, which could include shutting down institutions that use such currencies, Choi said.
As bitcoin's value continues to fluctuate, how will investors reduce risk exposure to the currency's volatility?
This is so neither the customer or Stripe has to hold on to the virtual currency, which will allow both parties to reduce the risk of price volatility.
a b c d e f g h i j k l m n o p q r s t u v w x y z